Skip to main content

Table 2 Medical History Timeline

From: SLC4A4 compound heterozygous mutations in exon–intron boundary regions presenting with severe proximal renal tubular acidosis and extrarenal symptoms coexisting with Turner’s syndrome: a case report

Year

Clinical findings

Diagnosis

2011-

 

Bilateral glaucoma was found; Sholl solution and anti-acidosis capsule was prescribed

2015

Physical Examination: Weight and height, below the 3rd percentile; Mental retardation. Other physical examinations, neurological signs: unremarkable.

Serum: Na, 139 mEq/L; K, 3.1 mEq/L; Cl, 110 mEq/L; blood urea nitrogen, 12 mg/dL; creatinine, 0.9 mg/dL, pH, 7.22; HCO3, 11 mmol/L; PCO2, 29 mmHg. Free T4, TSH, IGF-I, IGFBP3; normal.

Urinalysis: pH, 5.0; no protein; no glucose. Urinary excretion of amino acids, normal; β2-microglobulin, 110 μg/L (normal: <  240 μg/L).

Renal ultrasound, a 9-mm diameter parenchymal stone in the right kidney.

Brain MR imaging, no intracranial calcification.

Diagnosed as proximal renal tubular acidosis

Identification of slc4a4 mutation

2017

Weight, 21 kg (<3rd percentile); height, 116 cm (<3rd percentile).

Physical examination: micrognathia, “fish-mouth” appearance, dental abnormalities, epicantal folds, ptosis, low-set ears, short neck with low hairline, broad shield-like chest, wide-spaced nipples, hypoplastic areolaes, cubitus valgus, short fourth metacarpals.

Hormonal investigations: FSH, 69.3 IU/L (normal: 4.5–20.0 mIU/L); LH, 15.9 IU/L (normal: 3.5–14.0 mIU/L) and estradiol, < 5.0 pg/mL.

Karyotype, 45.

Obstetric ultrasound; uterine and gonadal hypoplasia.

Diagnosed as Turner’s syndrome